409 related articles for article (PubMed ID: 1967305)
21. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.
Shapiro B; Copp JE; Sisson JC; Eyre PL; Wallis J; Beierwaltes WH
J Nucl Med; 1985 Jun; 26(6):576-85. PubMed ID: 2860214
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m-pentavalent dimercaptosuccinic acid uptake in Hurthle cell tumor of the thyroid.
Vergara E; Lastoria S; Varrella P; Lapenta L; Salvatore M
J Nucl Biol Med (1991); 1993 Jun; 37(2):65-8. PubMed ID: 8396979
[TBL] [Abstract][Full Text] [Related]
23. Medullary carcinoma of the thyroid: management of persistent hypercalcitonaemia utilizing [99mTc] (v) dimercaptosuccinic acid scintigraphy.
Udelsman R; Mojiminiyi OA; Soper ND; Buley ID; Shepstone BJ; Dudley NE
Br J Surg; 1989 Dec; 76(12):1278-81. PubMed ID: 2557953
[TBL] [Abstract][Full Text] [Related]
24. Limitations of 131I-MIBG scintigraphy in locating pheochromocytomas.
Gough IR; Thompson NW; Shapiro B; Sisson JC
Surgery; 1985 Jul; 98(1):115-20. PubMed ID: 2861667
[TBL] [Abstract][Full Text] [Related]
25. Experience in imaging medullary thyroid carcinoma using 99mTc (V) dimercaptosuccinic acid (DMSA).
Clarke S; Lazarus C; Maisey M
Henry Ford Hosp Med J; 1989; 37(3-4):167-8. PubMed ID: 2576956
[TBL] [Abstract][Full Text] [Related]
26. More on [99mTc](V)DMSA scintigraphy in patients with medullary carcinoma of the thyroid.
Mojiminiyi OA; Udelsman R; Shepstone BJ; Dudley NE; Soper ND
J Nucl Med; 1989 Aug; 30(8):1420. PubMed ID: 2547036
[No Abstract] [Full Text] [Related]
27. Detection of hepatic metastasis from medullary thyroid cancer with Tc-99m-MIBI scintigraphy in a patient with Sipple's syndrome.
Sato S; Okumura Y; Tamizu A; Maki K; Akaki S; Takeda Y; Kanazawa S; Hiraki Y
Ann Nucl Med; 2001 Oct; 15(5):443-6. PubMed ID: 11758951
[TBL] [Abstract][Full Text] [Related]
28. Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid.
Hilditch TE; Murray T; Connell JM; McLellan AR; Reed NS
J Nucl Med; 1988 Oct; 29(10):1746-7. PubMed ID: 2845025
[No Abstract] [Full Text] [Related]
29. [Adrenal gland scintigraphy].
Fischer M; Vetter H
Radiologe; 1986 Apr; 26(4):181-5. PubMed ID: 3012627
[TBL] [Abstract][Full Text] [Related]
30. Presurgical diagnosis of a primary carcinoid tumor of the thymus with MIBG.
Hirano T; Otake H; Watanabe N; Oriuchi N; Zennyouji A; Fukuda T; Endo K
J Nucl Med; 1995 Dec; 36(12):2243-5. PubMed ID: 8523113
[TBL] [Abstract][Full Text] [Related]
31. False-positive uptake of Tc-99m penta-DMSA in fibrous dysplasia of breast in a patient with medullary carcinoma of thyroid.
Mudun A; Unal S; Ilhan R; Aktay R; Demiryont M; Cantez S
Clin Nucl Med; 1994 Apr; 19(4):364-5. PubMed ID: 7911752
[No Abstract] [Full Text] [Related]
32. [Medullary carcinoma of the thyroid and 99mTc(V)-DMSA scintigraphy. Clinical results with a new radiopharmaceutical].
Kujat C; Neidl K; Müller-Leisse C
Rofo; 1990 Nov; 153(5):495-500. PubMed ID: 2173051
[TBL] [Abstract][Full Text] [Related]
33. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers.
Jansson S; Tisell LE; Fjälling M; Lindberg S; Jacobsson L; Zachrisson BF
Surgery; 1988 Jan; 103(1):11-8. PubMed ID: 2892276
[TBL] [Abstract][Full Text] [Related]
34. Technetium-99m(V)-DMSA in the imaging of medullary thyroid carcinoma.
J Nucl Med; 1987 Feb; 28(2):252-3. PubMed ID: 3027281
[No Abstract] [Full Text] [Related]
35. Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study.
Baulieu JL; Guilloteau D; Delisle MJ; Perdrisot R; Gardet P; Delépine N; Baulieu F; Dupont JL; Talbot JN; Coutris G
Cancer; 1987 Nov; 60(9):2189-94. PubMed ID: 2894239
[TBL] [Abstract][Full Text] [Related]
36. Imaging and uptake mechanism of 131I-meta-iodobenzylguanidine in medullary thyroid carcinoma.
Oishi S; Sasaki M; Sato T; Hirota Y; Takahashi M
Endocrinol Jpn; 1986 Jun; 33(3):309-15. PubMed ID: 2875869
[TBL] [Abstract][Full Text] [Related]
37. Positive scintigraphy of medullary thyroid cancer using 201Tl and alkalized 99mTc-DMSA.
Holub V; Nĕmec J; Neradilová M; Benová M; Blazek T; Dusek M
Radiobiol Radiother (Berl); 1987; 28(5):640-2. PubMed ID: 2831559
[No Abstract] [Full Text] [Related]
38. Methodology and dosimetry in adrenal medullary imaging with iodine-131 MIBG.
Lindberg S; Fjälling M; Jacobsson L; Jansson S; Tisell LE
J Nucl Med; 1988 Oct; 29(10):1638-43. PubMed ID: 2902204
[TBL] [Abstract][Full Text] [Related]
39. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid.
Clarke SE; Lazarus C; Mistry R; Maisey MN
Br J Radiol; 1987 Nov; 60(719):1089-92. PubMed ID: 2825895
[TBL] [Abstract][Full Text] [Related]
40. Tc-99m DMSA scintigraphy on patients with medullary thyroid carcinoma.
Groth P; Unterspann S; Schwähn D; Stoll I; Reincke R
Radiobiol Radiother (Berl); 1987; 28(5):642-4. PubMed ID: 2831560
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
